Skip to main content

Table 1 Correlations between JPX and clinical characteristics of 116 lung cancer patients

From: lncRNA JPX/miR-33a-5p/Twist1 axis regulates tumorigenesis and metastasis of lung cancer by activating Wnt/β-catenin signaling

  n lncRNA JPX level χ2 test P value
Characteristics   High Low   
Total cases 116 58 58   
Gender
 Male 66 34 32 0.1406 0.7077
 Female 50 24 26   
Age (years)
  ≤ 60 40 18 22 0.6105 0.4346
 >60 76 40 36   
Smoking history
 Yes 47 26 21 0.8942 0.3443
 No 69 32 37   
Histology
 Adenocarcinoma 84 41 43 0.2015 0.9042
 Squamous carcinoma 26 14 12   
 Other type 6 3 3   
Tumor location
 Left 55 24 31 1.694 0.193
 Right 61 34 27   
Differentiation
 High and moderate 21 11 10 0.05815 0.8095
 Poor 95 47 48   
Tumor size(cm)
  ≤ 3 84 34 50 11.05 0.0009**
 >3 32 24 8   
TNM stage
 I + II 87 35 52 13.29 0.0003***
 III + IV 29 23 6   
  1. †Median expression level was used as cutoff. Low expression of JPX in 116 patients was defined as a value below the 50th percentile, and high above the 50th percentile. P values were acquired by Pearson’s chi-square test. **P < 0.01, ***P < 0.001